MetaCap

Monte Rosa Therapeutics Insider Trades

NASDAQ: GLUEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

10.30-0.02 (-0.19%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
37 · $4.11M
Shares bought / sold
0 / 207.82K
Net activity
Net selling $4.1 million

Monte Rosa Therapeutics insider activity

Over the last 12 months, Monte Rosa Therapeutics insiders reported 63 transactions on SEC Form 4: 0 open-market purchases and 37 sales. Insiders bought $0 and sold $4.1 million worth of stock, for net insider selling of $4.1 million. The largest seller was Janku Filip, with $1.4 million in reported sales.

The most recent filing shows Bowen Matthew (Principal Accounting Officer) selling 13 shares at $10.56 on Oct 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GLUE's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GLUE insider transactions

Monte Rosa Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Oct 5, 2026Bowen MatthewPrincipal Accounting OfficerSale13$137.28Form 4
Jul 16, 2026Warmuth MarkusPresident & CEOSale9,500$220.22KForm 4
Jul 15, 2026Champoux JenniferChief Operating OfficerSale4,351$101.73KForm 4
Jul 15, 2026Champoux JenniferChief Operating OfficerOption exercise4,351$17.32KForm 4
Jul 6, 2026Townson SharonChief Scientific OfficerSale400$9.65KForm 4
Jul 6, 2026Townson SharonChief Scientific OfficerSale5,600$130.20KForm 4
Jul 6, 2026Townson SharonChief Scientific OfficerOption exercise6,000$36.84KForm 4
Jul 1, 2026Behbahani AliDirectorother15,000—Form 4
Jul 1, 2026Behbahani AliDirectorother15,000—Form 4
Jul 1, 2026Behbahani AliDirectorother1,000,000—Form 4
Jun 30, 2026Janku FilipChief Medical OfficerSale5,407$132.47KForm 4
Jun 30, 2026Janku FilipChief Medical OfficerOption exercise5,407$72.51KForm 4
Jun 29, 2026Manning Anthony M.DirectorSale10,000$231.10KForm 4
Jun 29, 2026Manning Anthony M.DirectorOption exercise10,000$41.60KForm 4
Jun 29, 2026Janku FilipChief Medical OfficerSale6,000$137.70KForm 4
Jun 29, 2026Janku FilipChief Medical OfficerOption exercise6,000$45.36KForm 4
Jun 24, 2026Janku FilipChief Medical OfficerSale30,000$642.68KForm 4
Jun 24, 2026Janku FilipChief Medical OfficerOption exercise30,000$226.80KForm 4
Jun 23, 2026Townson SharonChief Scientific OfficerSale3,000$60.00KForm 4
Jun 23, 2026Townson SharonChief Scientific OfficerOption exercise3,000$18.42KForm 4
Jun 23, 2026Champoux JenniferChief Operating OfficerSale2,175$43.50KForm 4
Jun 23, 2026Champoux JenniferChief Operating OfficerOption exercise2,175$8.66KForm 4
Jun 23, 2026Janku FilipChief Medical OfficerSale11,845$239.52KForm 4
Jun 23, 2026Janku FilipChief Medical OfficerOption exercise6,000$45.36KForm 4
Jun 17, 2026Champoux JenniferChief Operating OfficerSale2,176$41.34KForm 4
Jun 17, 2026Champoux JenniferChief Operating OfficerOption exercise2,176$8.66KForm 4
Jun 17, 2026Townson SharonChief Scientific OfficerSale3,000$57.00KForm 4
Jun 17, 2026Townson SharonChief Scientific OfficerOption exercise3,000$18.42KForm 4
Jun 1, 2026Warmuth MarkusPresident & CEOSale468$9.23KForm 4
Jun 1, 2026Warmuth MarkusPresident & CEOSale4,998$97.02KForm 4
May 29, 2026Townson SharonChief Scientific OfficerSale6,000$119.22KForm 4
May 29, 2026Townson SharonChief Scientific OfficerOption exercise6,000$36.84KForm 4
May 27, 2026Champoux JenniferChief Operating OfficerSale2,175$43.50KForm 4
May 27, 2026Champoux JenniferChief Operating OfficerOption exercise2,175$8.66KForm 4
May 22, 2026Champoux JenniferChief Operating OfficerSale2,176$41.34KForm 4
May 22, 2026Champoux JenniferChief Operating OfficerOption exercise2,176$8.66KForm 4
May 21, 2026Manning Anthony M.DirectorSale10,000$180.10KForm 4
May 21, 2026Manning Anthony M.DirectorOption exercise10,000$41.60KForm 4
May 1, 2026Warmuth MarkusPresident & CEOSale5,467$103.45KForm 4
Apr 14, 2026Warmuth MarkusPresident & CEOSale8,000$141.12KForm 4
Apr 9, 2026Nickson PhilipChief Business & Legal OfficerSale5,845$103.41KForm 4
Apr 6, 2026Bowen MatthewPrincipal Accounting OfficerAward4,300—Form 4
Mar 4, 2026Dunn EdmundPrincipal Accounting OfficerSale139$2.50KForm 4
Mar 2, 2026Dunn EdmundPrincipal Accounting OfficerSale536$9.38KForm 4
Mar 2, 2026Dunn EdmundPrincipal Accounting OfficerOption exercise536$7.19KForm 4
Mar 2, 2026Warmuth MarkusPresident & CEOSale5,466$97.97KForm 4
Feb 27, 2026Dunn EdmundPrincipal Accounting OfficerSale25,164$455.51KForm 4
Feb 27, 2026Dunn EdmundPrincipal Accounting OfficerOption exercise25,164$337.45KForm 4
Feb 23, 2026Janku FilipChief Medical OfficerSale9,189$179.16KForm 4
Jan 7, 2026Warmuth MarkusPresident & CEOSale309$7.59KForm 4
Jan 7, 2026Warmuth MarkusPresident & CEOSale1,450$34.62KForm 4
Jan 7, 2026Warmuth MarkusPresident & CEOSale3,707$86.16KForm 4
Jan 5, 2026Townson SharonChief Scientific OfficerSale3,155$47.86KForm 4
Jan 5, 2026Janku FilipChief Medical OfficerSale3,155$47.86KForm 4
Jan 5, 2026Warmuth MarkusPresident & CEOSale10,135$153.75KForm 4
Jan 5, 2026Dunn EdmundPrincipal Accounting OfficerSale1,039$15.76KForm 4
Jan 5, 2026Champoux JenniferChief Operating OfficerSale2,629$39.88KForm 4
Jan 5, 2026Nickson PhilipChief Business & Legal OfficerSale3,155$47.86KForm 4
Jan 2, 2026Townson SharonChief Scientific OfficerAward35,000—Form 4
Jan 2, 2026Janku FilipChief Medical OfficerAward31,000—Form 4
Jan 2, 2026Warmuth MarkusPresident & CEOAward90,000—Form 4
Jan 2, 2026Champoux JenniferChief Operating OfficerAward35,000—Form 4
Jan 2, 2026Nickson PhilipChief Business & Legal OfficerAward28,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related